Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-term Care Facility Staff With and Without Prior Infection in New York City, January–June 2021

BACKGROUND: Evidence is accumulating of coronavirus disease 2019 (COVID-19) vaccine effectiveness among persons with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. METHODS: We evaluated the effect against incident SARS-CoV-2 infection of (1) prior infection without vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Peebles, Kathryn, Arciuolo, Robert J, Romano, Anthony S, Sell, Jessica, Greene, Sharon K, Lim, Sungwoo, Mulready-Ward, Candace, Ternier, Alexandra, Badenhop, Brittan, Blaney, Kathleen, Real, Joseph E, Spencer, Magdalene, McPherson, Tristan D, Ahuja, Shama Desai, Sullivan Meissner, Jeanne, Zucker, Jane R, Rosen, Jennifer B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927076/
https://www.ncbi.nlm.nih.gov/pubmed/36626187
http://dx.doi.org/10.1093/infdis/jiac448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927076/
https://www.ncbi.nlm.nih.gov/pubmed/36626187
http://dx.doi.org/10.1093/infdis/jiac448

Ejemplares similares